MIMEDX GROUP, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD

On Monday, November 22, 2021, Timothy R. Wright, MiMedx Chief Executive Officer, and Rohit Kashyap, Ph.D., MiMedx Chief Commercial Officer, are expected to present at the Piper Sandler 33rd Annual Healthcare Conference on behalf of MiMedx Group, Inc. (the "Company" or "MiMedx"), beginning at 10:00 a.m. Eastern Time. A copy of the presentation materials they will use are attached hereto as Exhibit 99.1 and are incorporated herein for reference. The presentation materials shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section and shall only be incorporated by reference into another filing under the Exchange Act or Securities Act of 1933 if such subsequent filing specifically references this Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.
Exhibit No.              Description of Exhibit
99.1                       Slide Presentation dated November 22, 2021
                         The cover page from this Current Report on Form 8-K, formatted in Inline
104                      XBRL.

© Edgar Online, source Glimpses